Amir London
Chief Executive OfficerMr. Amir London has been the Chief Executive Officer at Kamada Ltd. since July 1, 2015. Mr. London served as an Senior Vice President of Business Development at Kamada Ltd. from December 9, 2013 to July 1, 2015. Mr. London leads Kamada's commercial strategy and business development efforts to advance the market opportunities for the protein therapeutics platform through a variety of initiatives including collaborations and partnerships, as well as enhancing Kamada's sales infrastructure. Mr. London served as General Manager of Promedico Ltd. He joined Promedico in beginning of 2009. Mr. London served as the Chief Executive Officer of Promedico until 2011. Mr. London served as a Partner of Tefen Industrial Engineering and Management & Systems Analysis and Tefen Ltd. from 1995 to 2006. He was General Manager of Cure Medical, from 2006 to 2009. He served as Chief Operating Officer of Fidelis Diagnostics, where he was responsible for global biopharmaceutical practice. He has over 20 years of international managerial and business development experience, mainly in the pharmaceutical industry. He holds a B.Sc. degree in Industrial and Management Engineering from the Technion – Israel Institute of Technology.
Positions
- Company NameKamada Ltd.Stock CodeKMDAPositionChief Executive OfficerColleagues
- LALilach Asher-TopilskyIndependent Chairman of the Board
- COChaime OrlevChief Financial Officer
- ENEran NirChief Operating Officer
- JRJon R. KnightVice President of US Commercial Operations
- BGBoris GorelikVice President of Business Development & Strategic Programs
- DTDavid TsurCo-Founder & Independent Deputy Chairman of the Board
- AIAssaf ItshayekIndependent External Director
- LYLeon Y. RecanatiIndependent Director
- IDIshay DavidiIndependent Director
